Reach Us +44-1904-929220
The Balance Of Serum Matrix Metalloproteinase-8 And Its Tissue Inhibitor In Acute Coronary Syndrome And Its Recurrence | 3533

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence

3rd International Conference on Biomarkers & Clinical Research

Erkki Pesonen, Seppo Sarna, Mirja Puolakkainen, Hans �hlin, Timo Sorsa and Pirkko J. Pussinen

ScientificTracks Abstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.009

Introduction: Matrix metalloproteinase-8 (MMP-8) is involved in the breakdown of the extracellular matrix increasing the vulnerability of atherosclerotic lesions. MMPs are endogenously inhibited by the specific tissue inhibitor of metalloproteinases (TIMP-1). Methods: Sera were collected from 343 patients with ACS [including108 unstable angina pectoris and 235 acute myocardial infarctions] within 24 hours after the diagnosis and three to six months after the acute event during the recovery period (n=157). Serum MMP-8 concentrations were determined by a time-resolved immunofluorometric assay. 326 age- and sex-matched subjects served as controls. Results: The ACS patients had high IgG-class antibody levels to chlamydial heat shock protein 60 and the levels correlated with serum TIMP-1 concentrations (r=0.225, p=0.001). High serum MMP-8 and TIMP-1 concentrations (4th quartile vs. 1st) associated with ACS. The trend from quartile 1 to 4 was very significant (p<0.001). A strong direct association was found between TIMP-1 concentration and CVD death during the follow-up. Acute phase and recovery period TIMP-1 concentrations associated with cardiovascular death with hazard ratios 4.31 (2.00�9.26, p<0.001) and 4.69 (1.10�20.01, p = 0.037), respectively. Conclusions: A persistent inflammation existed before the acute event. The increase of serum MMP-8 and TIMP-1 concentrations may reflect plaque instability and tissue damage. TIMP-1 may exert a continuous damaging stimulus promoting inflammation. If TIMP-1 is �over produced� as a response to acute phase MMP-8 expression or if its production is not suppressed enough during the recovery, the prognosis is poor. The fndings may have practical implications in both diagnostics and therapeutics.
Relevant Topics